These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 3571694)

  • 1. Fatal outcome in a metatypical, giant, "horrifying" basal cell carcinoma.
    Bianchini R; Wolter M
    J Dermatol Surg Oncol; 1987 May; 13(5):556-7. PubMed ID: 3571694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metatypical Basal Cell Carcinoma: A 6-Year Retrospective Study.
    Chaabane A; Bacha D; Ayachi K; Kilani H; Kanchel F; Douggaz A; Nechi S; Chelbi E
    Skinmed; 2019; 17(1):24-28. PubMed ID: 30888944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastatic basal cell carcinoma: report of two cases and literature review.
    Ting PT; Kasper R; Arlette JP
    J Cutan Med Surg; 2005 Jan; 9(1):10-5. PubMed ID: 16208438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Histologic risk factors of basal cell carcinoma of the face, about 184 cases].
    Wavreille O; Martin De Lassalle E; Wavreille G; Mortier L; Martinot Duquennoy V
    Ann Chir Plast Esthet; 2012 Dec; 57(6):542-8. PubMed ID: 22534511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basal cell carcinoma with mixed histology: a possible pathogenesis for recurrent skin cancer.
    Cohen PR; Schulze KE; Nelson BR
    Dermatol Surg; 2006 Apr; 32(4):542-51. PubMed ID: 16681663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical study of primary and recurrent basal cell and metatypical carcinomas of the skin.
    Kazantseva IA; Khlebnikova AN; Babaev VR
    Am J Dermatopathol; 1996 Feb; 18(1):35-42. PubMed ID: 8721589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence of ulceration, but not high risk zone location, correlates with unfavorable histopathological subtype in facial basal cell carcinoma.
    Yalcin O; Sezer E; Kabukcuoglu F; Kilic AI; Sari AG; Cerman AA; Altunay IK
    Int J Clin Exp Pathol; 2015; 8(11):15448-53. PubMed ID: 26823913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Metatypical basaloma. A case report].
    Rodiek SO
    Radiologe; 1983 Oct; 23(10):480-2. PubMed ID: 6647834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The curious case of a forehead metatypical basal cell carcinoma.
    Florescu IP; Turcu EG; Carantino AM; Cocoşilă LC; Enache V; Neagu TP; Jecan CR
    Rom J Morphol Embryol; 2018; 59(1):345-352. PubMed ID: 29940648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duplicitous growth of infiltrative basal cell carcinoma: Analysis of clinically undetected tumor extent in a paired case-control study.
    Hendrix JD; Parlette HL
    Dermatol Surg; 1996 Jun; 22(6):535-9. PubMed ID: 8646468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mohs' micrographic surgery for treatment of basal cell carcinoma of the face--results of a retrospective study and review of the literature.
    Smeets NW; Kuijpers DI; Nelemans P; Ostertag JU; Verhaegh ME; Krekels GA; Neumann HA
    Br J Dermatol; 2004 Jul; 151(1):141-7. PubMed ID: 15270883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Facial basal cell carcinoma with successive metastases to the neck, thyroid gland and lung.
    Thiele OC; Mertens C; Bacon C; Flechtenmacher C; Zaoui K; Mischkowski RA
    J Craniomaxillofac Surg; 2014 Jul; 42(5):489-91. PubMed ID: 23849247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and pathologic parameters predicting recurrence of facial basal cell carcinoma: a retrospective audit in an advanced care center.
    Troeltzsch M; Probst FA; Knösel T; Mast G; Ehrenfeld M; Otto S
    Int J Dermatol; 2016 Nov; 55(11):1281-1288. PubMed ID: 27420481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrence rates of aggressive histologic types of basal cell carcinoma after treatment with electrodesiccation and curettage alone.
    Blixt E; Nelsen D; Stratman E
    Dermatol Surg; 2013 May; 39(5):719-25. PubMed ID: 23379543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of p53, D2-40 and α-smooth muscle actin in different histological subtypes of facial basal cell carcinoma.
    Mercut R; Ciurea ME; Mărgăritescu C; Popescu SM; Crăitoiu MM; Cotoi OS; Voinescu DC
    Rom J Morphol Embryol; 2014; 55(2):263-72. PubMed ID: 24969973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Basalioma].
    Diem E
    Ther Umsch; 1993 Dec; 50(12):812-6. PubMed ID: 8171402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late recurrent basal cell carcinoma presenting as a unilateral exophthalmos.
    Tomich JM; Wagner RF
    J Dermatol Surg Oncol; 1986 Aug; 12(8):866-8. PubMed ID: 3734239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Proliferative activity of basal cell and metatypical cell carcinoma of the skin].
    Kazantseva IA; Khlebnikova AN; Babaev VR; Fager G
    Arkh Patol; 1994; 56(4):35-8. PubMed ID: 7848103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basal cell carcinoma with hepatic metastases.
    Postlethwaite KR; Courtney DJ; Gosney JR
    Br J Oral Maxillofac Surg; 1990 Apr; 28(2):111-3. PubMed ID: 2337561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for recurrence of facial basal cell carcinoma after surgical excision: A follow-up analysis.
    Armstrong LTD; Magnusson MR; Guppy MPB
    J Plast Reconstr Aesthet Surg; 2017 Dec; 70(12):1738-1745. PubMed ID: 28579037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.